Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 183

1.

Burden of comorbidities among patients with atrial fibrillation.

LaMori JC, Mody SH, Gross HJ, daCosta DiBonaventura M, Patel AA, Schein JR, Nelson WW.

Ther Adv Cardiovasc Dis. 2013 Apr;7(2):53-62. doi: 10.1177/1753944712464101. Epub 2012 Oct 22.

PMID:
23090783
2.

Dyspepsia and disease burden among patients with atrial fibrillation.

LaMori JC, Mody SH, Gross HJ, DiBonaventura Md, Patel A, Schein J, Nelson WW.

Crit Pathw Cardiol. 2012 Mar;11(1):14-9. doi: 10.1097/HPC.0b013e318246fae8.

PMID:
22337216
3.

Management and comorbidities of atrial fibrillation in patients admitted in cardiology service in Kosovo-a single-center study.

Elezi S, Qerkini G, Bujupi L, Shabani D, Bajraktari G.

Anadolu Kardiyol Derg. 2010 Feb;10(1):36-40.

4.

Prevalence of stroke and the need for thromboprophylaxis in young patients with atrial fibrillation: a cohort study.

Lin AH, Oakley LS, Phan HL, Shutt BJ, Birgersdotter-Green U, Francisco GM.

J Cardiovasc Med (Hagerstown). 2014 Mar;15(3):189-93. doi: 10.2459/JCM.0b013e3283654c4b.

PMID:
24625564
5.

The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.

Olesen JB, Torp-Pedersen C, Hansen ML, Lip GY.

Thromb Haemost. 2012 Jun;107(6):1172-9. doi: 10.1160/TH12-03-0175. Epub 2012 Apr 3.

PMID:
22473219
6.

Are atrial fibrillation patients receiving warfarin in accordance with stroke risk?

Zimetbaum PJ, Thosani A, Yu HT, Xiong Y, Lin J, Kothawala P, Emons M.

Am J Med. 2010 May;123(5):446-53. doi: 10.1016/j.amjmed.2009.11.015.

PMID:
20399322
7.

Comorbidity associated with atrial fibrillation: a general practice-based study.

Carroll K, Majeed A.

Br J Gen Pract. 2001 Nov;51(472):884-6, 889-91.

8.

Preventing stroke in people with atrial fibrillation: a cross-sectional study.

de Lusignan S, van Vlymen J, Hague N, Thana L, Dzregah B, Chan T.

J Public Health (Oxf). 2005 Mar;27(1):85-92. Epub 2004 Dec 8.

PMID:
15590708
9.

[Atrial fibrillation, comorbidities and new anticoagulants].

De Decker L, Gegu M, Chevalet P, Berrut G.

Geriatr Psychol Neuropsychiatr Vieil. 2013 Dec;11(1 Suppl):10-6. doi: 10.1684/pnv.2013.0447. Review. French.

PMID:
24463059
10.

Warfarin and Aspirin Use for Stroke Prevention Among Patients With Atrial Fibrillation: The US National Health and Wellness Survey.

Goren A, Liu X, Gupta S, Simon TA, Phatak H.

Am J Ther. 2015 Jul-Aug;22(4):248-56. doi: 10.1097/MJT.0000000000000001.

PMID:
24326696
11.

Diagnosis and management of atrial fibrillation by primary care physicians in Italy : a retrospective, observational analysis.

Piccinocchi G, Laringe M, Guillaro B, Arpino G, Piccinocchi R, Nigro G, Calabrò P.

Clin Drug Investig. 2012 Nov;32(11):771-7. doi: 10.1007/s40261-012-0005-5.

12.

Stroke prevention in elderly patients with atrial fibrillation.

Lew SJ, Lim JK.

Singapore Med J. 2002 Apr;43(4):198-201.

PMID:
12188065
13.

Assessment of baseline characteristics and risk factors among Emergency Department patients presenting with recent onset atrial fibrillation: a retrospective cohort study.

Buccelletti F, Di Somma S, Iacomini P, Galante A, Pugliese F, Alegiani F, Bertazzoni G, Marsiliani D, Carroccia A, Granato A, Calabrò G, Legramante JM, Zuccalà G, Franceschi F.

Eur Rev Med Pharmacol Sci. 2013 Feb;17 Suppl 1:22-7.

14.

Vitamin K antagonists in patients with nonvalvular atrial fibrillation: appropriateness and quality of treatment in an Italian cohort.

Pereira de Sousa L, Burba I, Ruperto C, Lattuada L, Barbone F, Di Chiara A.

J Cardiovasc Med (Hagerstown). 2013 Jul;14(7):534-40. doi: 10.2459/JCM.0b013e32835dbd58.

PMID:
23328227
15.

Atrial fibrillation prevalence revisited.

Friberg L, Bergfeldt L.

J Intern Med. 2013 Nov;274(5):461-8. doi: 10.1111/joim.12114. Epub 2013 Aug 7.

16.

Association between atrial fibrillation, anticoagulation, risk of cerebrovascular events and multimorbidity in general practice: a registry-based study.

Vanbeselaere V, Truyers C, Elli S, Buntinx F, De Witte H, Degryse J, Henrard S, Vaes B.

BMC Cardiovasc Disord. 2016 Mar 28;16:61. doi: 10.1186/s12872-016-0235-1.

17.

Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation.

Anderson DR, Gardner MJ, Putnam W, Jassal D, Brownell B, Flowerdew G, Nagpal S, Thompson K, Cox JL.

Can J Cardiol. 2005 Mar;21(3):257-66.

PMID:
15776115
18.

Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin.

Gage BF, van Walraven C, Pearce L, Hart RG, Koudstaal PJ, Boode BS, Petersen P.

Circulation. 2004 Oct 19;110(16):2287-92. Epub 2004 Oct 11.

19.

Quality of anticoagulation with warfarin in patients with nonvalvular atrial fibrillation in the community setting.

Han SY, Palmeri ST, Broderick SH, Hasselblad V, Rendall D, Stevens S, Tenaglia A, Velazquez E, Whellan D, Wagner G, Heitner JF.

J Electrocardiol. 2013 Jan-Feb;46(1):45-50. doi: 10.1016/j.jelectrocard.2012.08.011. Epub 2012 Oct 11.

PMID:
23063241
20.

Quality of life, activity impairment, and healthcare resource utilization associated with atrial fibrillation in the US National Health and Wellness Survey.

Goren A, Liu X, Gupta S, Simon TA, Phatak H.

PLoS One. 2013 Aug 12;8(8):e71264. doi: 10.1371/journal.pone.0071264. eCollection 2013.

Supplemental Content

Support Center